News from the MCRC
MCRC Blog
03/01/2024
Congratulations to our students on passing their PhD vivas
We are thrilled to extend our congratulations to students from the Manchester Cancer Research Centre and Cancer Research UK Manchester Centre who have recently passed their PhD vivas.
Director's Update
20/12/2023
MCRC Director’s Update – December 2023
In the final update for 2023, Rob looks reflects on the year of cancer research, and celebrates the launch of the MCRC Annual Report.
MCRC Blog
07/12/2023
MCRC Annual Report 2022/2023 Available Now
The year's major achievements include opening our flagship new research building, milestones in clinical research and international partnerships.
Director's Update
27/11/2023
MCRC Director’s Update – November 2023
Partner News
15/11/2023
Dr Kelechi Njoku awarded the first Eve Appeal Fellowship
The Eve Appeal and North West Cancer Research have announced that they are funding Dr Kelechi Njoku, a senior clinical oncology specialty registrar and academic clinical lecturer from The University of Manchester, to develop a new, kinder, test to diagnose womb cancer.
Director's Update
30/10/2023
MCRC Director’s Update – October 2023
MCRC Blog
24/10/2023
Starting in Science Day 2023
On Saturday 30th September we invited four schools from across Greater Manchester to the Oglesby Cancer Research Centre for our annual Starting in Science Day.
Researcher Stories
13/10/2023
Charlotte Mellor wins BACR Student Impact Award 2023
Research Spotlight
13/10/2023
Researchers are investigating how to stop triple negative breast cancer spreading
Breast Cancer Now is helping Dr Sankari Nagarajan and her team discover why some triple negative breast cancers spread to other parts of the body and whether existing drugs can be repurposed to stop this from happening.
Research Spotlight
09/10/2023
Hereditary Cancers – Li Fraumeni Syndrome
Research Spotlight
04/10/2023
New research can help policymakers prioritise funding needs and allocate resource for cancer
The study found that 61% of all SPED trials focused on just three cancer types – colorectal, breast, and cervical cancer.
Director's Update
29/09/2023
MCRC Director’s Update – September 2023
Partner News
19/09/2023
Swinton cancer patient joins a clinical trial at The Christie at Oldham
Swinton cancer patient joins a clinical trial at The Christie at Oldham
Partner News
18/09/2023
Research to find new treatment for oesophageal cancer receives £500,000 funding from MRC
The funding will support work to investigate an ‘RNA therapeutic’ to activate the body's immune system.
